Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bruce Ferguson

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Pharmacotherapy|January 5, 2017
Perioperative Inotrope Therapy and Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery: Evidence of a Racial DisparityJimmy T Efird, Andy C Kiser, Patricia B Crane, et al.
Circulation|December 10, 2015
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV TrialRalf E Harskamp, John H Alexander, T Bruce Ferguson, et al.
The Annals of Thoracic Surgery|February 20, 2007
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgeryAbhinav Goyal, John H Alexander, Gail E Hafley, et al.
American Heart Journal|May 21, 2018
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design, David J Maron, Judith S Hochman, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
Journal of the American Heart Association|February 28, 2014
Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillationEthan J Anderson, Jimmy T Efird, Stephen W Davies, et al.
American Heart Journal|September 18, 2012
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year resultsRenato D Lopes, Judson B Williams, Rajendra H Mehta, et al.
Circulation|July 17, 2013
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart AssociationMary Ann Peberdy, Michael W Donnino, Clifton W Callaway, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2011
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials NetworkPeter K Smith, Robert E Michler, Y Joseph Woo, et al.
Journal of the American College of Cardiology|September 15, 2012
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCynthia M Tracy, Andrew E Epstein, Dawood Darbar, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Pharmacotherapy|January 5, 2017
Perioperative Inotrope Therapy and Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery: Evidence of a Racial DisparityJimmy T Efird, Andy C Kiser, Patricia B Crane, et al.
Circulation|December 10, 2015
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV TrialRalf E Harskamp, John H Alexander, T Bruce Ferguson, et al.
The Annals of Thoracic Surgery|February 20, 2007
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgeryAbhinav Goyal, John H Alexander, Gail E Hafley, et al.
American Heart Journal|May 21, 2018
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design, David J Maron, Judith S Hochman, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
Journal of the American Heart Association|February 28, 2014
Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillationEthan J Anderson, Jimmy T Efird, Stephen W Davies, et al.
American Heart Journal|September 18, 2012
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year resultsRenato D Lopes, Judson B Williams, Rajendra H Mehta, et al.
Circulation|July 17, 2013
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart AssociationMary Ann Peberdy, Michael W Donnino, Clifton W Callaway, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2011
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials NetworkPeter K Smith, Robert E Michler, Y Joseph Woo, et al.
Journal of the American College of Cardiology|September 15, 2012
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCynthia M Tracy, Andrew E Epstein, Dawood Darbar, et al.
Pageof 16